Low-dose IL-2 for patients with systemic lupus erythematosus

被引：1
|
作者：
He, Jing [1 ]
Sun, Xiaolin [1 ]
Li, Zhanguo [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China
来源：
LANCET RHEUMATOLOGY | 2019年 / 1卷 / 04期
关键词：
SAFETY;
D O I：
10.1016/S2665-9913(19)30107-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E203 / E203
页数：1
相关论文
共 50 条
  • [21] Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus
    Salido, M
    Macarron, P
    Hernández-García, C
    D'Cruz, DP
    Khamashta, MA
    Hughes, GRV
    LUPUS, 2003, 12 (08) : 636 - 639
  • [22] Local low-dose IL-2 therapy
    Den Otter, W
    Balemans, L
    Battermann, JJ
    Bernsen, MR
    Cadee, JA
    Dobrowolski, Z
    Everse, LA
    Fiszer-Maliszewska, L
    Gavhumende, R
    De Groot, JW
    De Groot, K
    Hennink, WE
    Hill, FWG
    Jurgenliemp-Schulz, I
    Klein, WR
    Koten, JW
    Maas, RA
    Steerenberg, P
    Stewart, R
    Zembala, M
    HEPATO-GASTROENTEROLOGY, 1999, 46 : 1280 - 1286
  • [23] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Weng, Meng-Yu
    Weng, Chia-Tse
    Liu, Ming-Fei
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 771 - 775
  • [24] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Meng-Yu Weng
    Chia-Tse Weng
    Ming-Fei Liu
    Clinical Rheumatology, 2010, 29 : 771 - 775
  • [25] REGULATORY T CELL ABNORMALITIES AND IL-2 DEFICIENCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    von Spee-Mayer, C.
    Wassermann, N.
    Rose, A.
    Alexander, T.
    Klocke, J.
    Humrich, J. Y.
    Riemekasten, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 822 - 823
  • [26] INCREASED SOLUBLE IL-2 RECEPTOR IN SERUM OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SAWADA, S
    HASHIMOTO, H
    IIJMA, S
    TOKANO, Y
    MATSUKAWA, Y
    TAKEI, M
    ISHIKAWA, H
    KANG, H
    TOMURA, K
    MITAMURA, K
    HASHIMOTO, S
    OBARA, T
    CLINICAL RHEUMATOLOGY, 1993, 12 (02) : 204 - 209
  • [27] Safety and Efficiency of Low-Dose Interleukin-2 Treatment in Systemic Lupus Erythematosus
    He, Jing
    Zhang, Xia
    Wei, Yunbo
    Sun, Xiaolin
    Guo, Jianping
    JIn, Yuebo
    Jia, Rulin
    Zhu, Lei
    Hou, Zhaohua
    Chen, Yaping
    An, Yuan
    Jia, Yuan
    Liu, Xu
    Ren, Limin
    Li, Ru
    Ye, Hua
    Chen, Shi
    Zhang, Xuewu
    Su, Yin
    Morand, Eric
    Di, Yu
    Li, Zhanguo
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [28] Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus
    Miao, M.
    Li, Y.
    Xu, D.
    Zhang, R.
    He, J.
    Sun, X.
    Li, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (05) : 867 - 871
  • [29] Safety and Efficiency of Low-Dose Interleukin-2 Treatment in Systemic Lupus Erythematosus
    He, Jing
    Zhang, Xia
    Sun, Xiaolin
    Guo, Jianping
    Wei, Yunbo
    Hou, Zhaohua
    Di, Yu
    Li, Zhanguo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S290 - S290
  • [30] SAFETY AND EFFICIENCY OF LOW-DOSE INTERLEUKIN-2 TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    He, J.
    Zhang, X.
    Yu, D.
    Li, Z-G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1075 - 1076
12345